ITMI20000422A0 - Sistemi terapeutici per forme farmaceutiche orali di principi attivi aventi sfavorevoli caratteristiche organolettiche - Google Patents

Sistemi terapeutici per forme farmaceutiche orali di principi attivi aventi sfavorevoli caratteristiche organolettiche

Info

Publication number
ITMI20000422A0
ITMI20000422A0 IT2000MI000422A ITMI20000422A ITMI20000422A0 IT MI20000422 A0 ITMI20000422 A0 IT MI20000422A0 IT 2000MI000422 A IT2000MI000422 A IT 2000MI000422A IT MI20000422 A ITMI20000422 A IT MI20000422A IT MI20000422 A0 ITMI20000422 A0 IT MI20000422A0
Authority
IT
Italy
Prior art keywords
active ingredients
oral pharmaceutical
pharmaceutical forms
organoleptic characteristics
therapeutic systems
Prior art date
Application number
IT2000MI000422A
Other languages
English (en)
Inventor
Roberto Villa
Massimo Pedrani
Mauro Ajani
Lorenzo Fossati
Original Assignee
Cip Ninety Two 92 S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cip Ninety Two 92 S A filed Critical Cip Ninety Two 92 S A
Priority to IT2000MI000422A priority Critical patent/IT1317871B1/it
Publication of ITMI20000422A0 publication Critical patent/ITMI20000422A0/it
Priority to DE60005819T priority patent/DE60005819T2/de
Priority to CNB008088942A priority patent/CN1173695C/zh
Priority to JP2001502812A priority patent/JP4790950B2/ja
Priority to MXPA01012889A priority patent/MXPA01012889A/es
Priority to DK00942044T priority patent/DK1183014T3/da
Priority to AT00942044T priority patent/ATE251449T1/de
Priority to CA002377301A priority patent/CA2377301C/en
Priority to ES00942044T priority patent/ES2208349T3/es
Priority to AU56801/00A priority patent/AU5680100A/en
Priority to PCT/EP2000/005356 priority patent/WO2000076478A1/en
Priority to RU2002100367/15A priority patent/RU2246293C2/ru
Priority to PT00942044T priority patent/PT1183014E/pt
Priority to TR2002/00562T priority patent/TR200200562T2/xx
Priority to US10/009,532 priority patent/US7431943B1/en
Priority to EP00942044A priority patent/EP1183014B1/en
Publication of ITMI20000422A1 publication Critical patent/ITMI20000422A1/it
Priority to NO20016108A priority patent/NO331642B1/no
Priority to HK02107843.2A priority patent/HK1046244B/zh
Application granted granted Critical
Publication of IT1317871B1 publication Critical patent/IT1317871B1/it
Priority to US11/268,500 priority patent/US7410651B2/en
Priority to US11/378,378 priority patent/US7410652B2/en
Priority to US12/210,969 priority patent/US8029823B2/en
Priority to JP2011000092A priority patent/JP5279851B2/ja
Priority to JP2011000091A priority patent/JP5279850B2/ja
Priority to US13/226,758 priority patent/US8895064B2/en
Priority to US13/249,839 priority patent/US20120021053A1/en
Priority to US13/462,409 priority patent/US8293273B2/en
Priority to US13/462,430 priority patent/US20120220559A1/en
Priority to US13/477,592 priority patent/USRE43799E1/en
Priority to US13/585,190 priority patent/US9132093B2/en
Priority to US13/597,867 priority patent/US20120321710A1/en
Priority to US13/617,138 priority patent/US8784888B2/en
Priority to US13/660,308 priority patent/US20130053360A1/en
Priority to US14/308,305 priority patent/US9532954B2/en
Priority to US14/308,279 priority patent/US9320716B2/en
Priority to US14/491,363 priority patent/US9192581B2/en
Priority to US14/514,967 priority patent/US20150056279A1/en
Priority to US14/832,845 priority patent/US20150352128A1/en
Priority to US15/202,962 priority patent/US9592203B2/en
Priority to US15/369,296 priority patent/US10064878B2/en
Priority to US15/368,911 priority patent/US9737489B2/en
Priority to US15/646,330 priority patent/US10143698B2/en
Priority to US15/646,585 priority patent/US10052286B2/en
Priority to US15/646,538 priority patent/US10105374B2/en
Priority to US16/132,718 priority patent/US20190015428A1/en
Priority to US16/139,672 priority patent/US20190022112A1/en
Priority to US16/234,951 priority patent/US20190134061A1/en

Links

IT2000MI000422A 1999-06-14 2000-03-03 Sistemi terapeutici per forme farmaceutiche orali di principi attiviaventi sfavorevoli caratteristiche organolettiche. IT1317871B1 (it)

Priority Applications (46)

Application Number Priority Date Filing Date Title
IT2000MI000422A IT1317871B1 (it) 2000-03-03 2000-03-03 Sistemi terapeutici per forme farmaceutiche orali di principi attiviaventi sfavorevoli caratteristiche organolettiche.
DE60005819T DE60005819T2 (de) 1999-06-14 2000-06-09 Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
CNB008088942A CN1173695C (zh) 1999-06-14 2000-06-09 控制释放与掩蔽味道的口服药物组合物
JP2001502812A JP4790950B2 (ja) 1999-06-14 2000-06-09 制御放出および味感遮蔽経口医薬組成物
MXPA01012889A MXPA01012889A (es) 1999-06-14 2000-06-09 Composiciones farmaceuticas orales de liberacion controlada y sabor disfrazado.
DK00942044T DK1183014T3 (da) 1999-06-14 2000-06-09 Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
AT00942044T ATE251449T1 (de) 1999-06-14 2000-06-09 Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
CA002377301A CA2377301C (en) 1999-06-14 2000-06-09 Controlled release and taste masking oral pharmaceutical compositions
ES00942044T ES2208349T3 (es) 1999-06-14 2000-06-09 Composiciones farmaceuticas administrables por via oral de liberacion controlada y enmascaradoras del sabor.
AU56801/00A AU5680100A (en) 1999-06-14 2000-06-09 Controlled release and taste masking oral pharmaceutical compositions
PCT/EP2000/005356 WO2000076478A1 (en) 1999-06-14 2000-06-09 Controlled release and taste masking oral pharmaceutical compositions
RU2002100367/15A RU2246293C2 (ru) 1999-06-14 2000-06-09 Фармацевтические композиции для перорального введения с регулируемым высвобождением активного ингредиента и маскируемым вкусом
PT00942044T PT1183014E (pt) 1999-06-14 2000-06-09 Composicoes farmaceuticas orais de libertacao controlada e de dissimulacao de sabor
TR2002/00562T TR200200562T2 (tr) 1999-06-14 2000-06-09 Vücutta kontrollü şekilde salgılanabilen ve nahoş tadı önleyebilen ağızdan alınmaya mahsus farmasötik bileşimler
US10/009,532 US7431943B1 (en) 1999-06-14 2000-06-09 Controlled release and taste masking oral pharmaceutical compositions
EP00942044A EP1183014B1 (en) 1999-06-14 2000-06-09 Controlled release and taste masking oral pharmaceutical compositions
NO20016108A NO331642B1 (no) 1999-06-14 2001-12-14 Kontrollert frigivelse- og smaksmaskerende orale farmasoytiske sammensetninger
HK02107843.2A HK1046244B (zh) 1999-06-14 2002-10-30 控制釋放與掩蔽味道的口服藥物組合物
US11/268,500 US7410651B2 (en) 1999-06-14 2005-11-08 Controlled release and taste masking oral pharmaceutical composition
US11/378,378 US7410652B2 (en) 1999-06-14 2006-03-20 Controlled release and taste masking oral pharmaceutical composition
US12/210,969 US8029823B2 (en) 1999-06-14 2008-09-15 Controlled release and taste masking oral pharmaceutical composition
JP2011000092A JP5279851B2 (ja) 1999-06-14 2011-01-04 制御放出および味感遮蔽経口医薬組成物
JP2011000091A JP5279850B2 (ja) 1999-06-14 2011-01-04 制御放出および味感遮蔽経口医薬組成物
US13/226,758 US8895064B2 (en) 1999-06-14 2011-09-07 Controlled release and taste masking oral pharmaceutical composition
US13/249,839 US20120021053A1 (en) 1999-06-14 2011-09-30 Controlled release and taste-masking oral pharmaceutical composition
US13/462,409 US8293273B2 (en) 1999-06-14 2012-05-02 Controlled release and taste masking oral pharmaceutical composition
US13/462,430 US20120220559A1 (en) 1999-06-14 2012-05-02 Controlled Release and Taste Masking Oral Pharmaceutical Composition
US13/477,592 USRE43799E1 (en) 1999-06-14 2012-05-22 Controlled release and taste masking oral pharmaceutical composition
US13/585,190 US9132093B2 (en) 1999-06-14 2012-08-14 Controlled release and taste making oral pharmaceutical composition
US13/597,867 US20120321710A1 (en) 1999-06-14 2012-08-29 Controlled Release and Taste Masking Oral Pharmaceutical Composition
US13/617,138 US8784888B2 (en) 1999-06-14 2012-09-14 Controlled release and taste masking oral pharmaceutical composition
US13/660,308 US20130053360A1 (en) 1999-06-14 2012-10-25 Controlled release and taste masking oral pharmaceutical composition
US14/308,305 US9532954B2 (en) 1999-06-14 2014-06-18 Controlled release and taste masking oral pharmaceutical compositions
US14/308,279 US9320716B2 (en) 1999-06-14 2014-06-18 Controlled release and taste masking oral pharmaceutical compositions
US14/491,363 US9192581B2 (en) 1999-06-14 2014-09-19 Controlled release and taste masking oral pharmaceutical composition
US14/514,967 US20150056279A1 (en) 1999-06-14 2014-10-15 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
US14/832,845 US20150352128A1 (en) 1999-06-14 2015-08-21 Controlled release and taste masking oral pharmaceutical composition
US15/202,962 US9592203B2 (en) 1999-06-14 2016-07-06 Controlled release and taste masking oral pharmaceutical composition
US15/369,296 US10064878B2 (en) 1999-06-14 2016-12-05 Controlled release and taste masking oral pharmaceutical compositions
US15/368,911 US9737489B2 (en) 1999-06-14 2016-12-05 Controlled release and taste masking oral pharmaceutical composition
US15/646,330 US10143698B2 (en) 1999-06-14 2017-07-11 Controlled release and taste masking oral pharmaceutical compositions
US15/646,585 US10052286B2 (en) 1999-06-14 2017-07-11 Controlled release and taste masking oral pharmaceutical composition
US15/646,538 US10105374B2 (en) 1999-06-14 2017-07-11 Controlled release and taste masking oral pharmaceutical compositions
US16/132,718 US20190015428A1 (en) 1999-06-14 2018-09-17 Controlled release and taste masking oral pharmaceutical compositions
US16/139,672 US20190022112A1 (en) 1999-06-14 2018-09-24 Controlled release and taste masking oral pharmaceutical compositions
US16/234,951 US20190134061A1 (en) 1999-06-14 2018-12-28 Controlled release and taste masking oral pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI000422A IT1317871B1 (it) 2000-03-03 2000-03-03 Sistemi terapeutici per forme farmaceutiche orali di principi attiviaventi sfavorevoli caratteristiche organolettiche.

Publications (3)

Publication Number Publication Date
ITMI20000422A0 true ITMI20000422A0 (it) 2000-03-03
ITMI20000422A1 ITMI20000422A1 (it) 2001-09-03
IT1317871B1 IT1317871B1 (it) 2003-07-15

Family

ID=11444307

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI000422A IT1317871B1 (it) 1999-06-14 2000-03-03 Sistemi terapeutici per forme farmaceutiche orali di principi attiviaventi sfavorevoli caratteristiche organolettiche.

Country Status (1)

Country Link
IT (1) IT1317871B1 (it)

Also Published As

Publication number Publication date
IT1317871B1 (it) 2003-07-15
ITMI20000422A1 (it) 2001-09-03

Similar Documents

Publication Publication Date Title
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
EG25542A (en) Oral dosge forms for propiverne or pharmaceutically acceptable salts thereof having prolonged release of the active agent
PL356358A1 (en) Solid dosage form of someticone for oral administration
NO20020976D0 (no) Retarderte, orale, farmasöytiske administreringsformer
HUP0501186A2 (en) Pharmaceutical compositions comprising active vitamin d compounds
EG23943A (en) Flash-melt oral dosage formulation
AU2001283563A1 (en) Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
HK1076723A1 (en) Highly selective norepinephrine reuptake inhibitors and the use for the preparation of the medicament thereof
DE69936002D1 (de) Angepasster löffel zur oralen medikamenten-verabreichung
NO20043998L (no) Oral administreringsform for tungtloselige basiske aktive virkestoffer
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
NO20034862D0 (no) Formulering med oksykodon for administrering en gang pr dag
IL172423A0 (en) Novel formulations for opioid -based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
HUP0400548A3 (en) Use of combinations of iop-reducing active inoredient for preparation of pharmaceutical compositions available for treatment glaucoma
HUP0203311A3 (en) New pharmaceutical compositions of prolonged effect
HUP0500638A3 (en) Flashmelt oral dosage formulation
HUP0303636A3 (en) Dihydronaphthalenederivative compounds and pharmaceutical compositions containing them as active ingredient
IS6021A (is) Lyfjasamsetningar sem innihalda sítalópram
HUP0102159A3 (en) Pharmaceutical composition for the treatment of rumen acidosis
AU8799001A (en) Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
PL349393A1 (en) Sulphonyloxazolamines as therapeutic active ingredients
ITMI20000422A0 (it) Sistemi terapeutici per forme farmaceutiche orali di principi attivi aventi sfavorevoli caratteristiche organolettiche
AU2002322424A8 (en) Novel methods and formulations for administration of active agents
EP1361866A4 (en) EMULSIONS AS SOLID DOSAGE FORMS FOR ORAL ADMINISTRATION
ATE340576T1 (de) Wirkstoff-kombination zur medikamentösen therapie der nikotinabhängigkeit